跳至主要内容
临床试验/NCT00420654
NCT00420654已完成不适用

Growth Hormone Treatment of Women With Turner Syndrome: Body Composition and Heart Function.

Britta E. Hjerrild1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2007年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
Body composition: fat mass and lean body mass

研究概览

简要总结

Growth hormone treatment is used in girls with Turner syndrome to increase final height. The aim of this study is to evaluate the effect of growth hormone treatment on body composition and heart function in adult women with Turner syndrome. The hypothesis is that the fat mass will decrease and lean body mass will increase. There is only very limited documentation of the effect on the heart in this study population.

详细描述

This study is a randomised, double-blinded, controlled clinical trial to evaluate the effect of growth hormone (GH) treatment on adult women with Turner syndrome. The endpoints will be changes in body composition and heart function evaluated by echocardiography (ECHO) and positron emission tomography (PET).

Phase one: 6 months of GH or placebo treatment. Phase two: "open label" all participants are treated with GH for 12 months. At baseline, healthy controls will be examined, but will not receive any treatment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Turner syndrome
  • Age 20-40

排除标准

  • Symptomatic heart disease
  • Anti hypertensive treatment
  • Untreated thyroid disease
  • Adipositas (BMI > 35)
  • Treatment with glucocorticoids
  • Pregnancy

研究组 & 干预措施

A1

Active Comparator

干预措施: Growth Hormone (Drug)

A2

Placebo Comparator

干预措施: Placebo (Drug)

A3

Other

干预措施: Healthy controls (Other)

结局指标

主要结局

Body composition: fat mass and lean body mass

时间窗: 6 months + 18 months

Myocardial perfusion and glucose uptake, evaluated by positron emission tomography

时间窗: 6 months

次要结局

  • Heart function evaluated by echocardiography (conventional and tissue doppler)(6 months + 18 months)
  • Lipid profile(6 months + 18 months)
  • 24 hour ambulatory blood pressure(6 months + 18 months)

研究者

发起方
Britta E. Hjerrild
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Britta E. Hjerrild

MD PhD Clinical assistent

University of Aarhus

研究点 (1)

Loading locations...

相似试验